Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,320
datasets available to search
ShareScore release 0.9.0
Dataset results
1,320 results for “degeneration”
Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration
ClinicalTrials.gov study NCT01086761. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00511706. IPD Sharing: Not stated. Countries: 9. Publications: 1.
A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD]
ClinicalTrials.gov study NCT04270747. IPD Sharing: Not stated. Countries: 18. Publications: 0.
Study for Recalcitrant Age Related Macular Degeneration
ClinicalTrials.gov study NCT01543568. IPD Sharing: Not stated. Countries: 1. Publications: 16.
Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
ClinicalTrials.gov study NCT02686658. IPD Sharing: NO. Countries: 7. Publications: 3.
Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration
ClinicalTrials.gov study NCT03034772. IPD Sharing: NO. Countries: 1. Publications: 2.
Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
ClinicalTrials.gov study NCT02540954. IPD Sharing: NO. Countries: 14. Publications: 1.
A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
ClinicalTrials.gov study NCT02247531. IPD Sharing: Not stated. Countries: 22. Publications: 7.
A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
ClinicalTrials.gov study NCT05019521. IPD Sharing: Not stated. Countries: 13. Publications: 1.
12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT01362348. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
ClinicalTrials.gov study NCT03525600. IPD Sharing: Not stated. Countries: 15. Publications: 5.
OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration
ClinicalTrials.gov study NCT00306488. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Low Vision Depression Prevention Trial for Age Related Macular Degeneration
ClinicalTrials.gov study NCT00769015. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)
ClinicalTrials.gov study NCT00891735. IPD Sharing: Not stated. Countries: 1. Publications: 21.
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00637377. IPD Sharing: Not stated. Countries: 26. Publications: 6.
Assessing the Quality of Life and Social Support in Age-Related Macular Degeneration Patients
ClinicalTrials.gov study NCT05427994. IPD Sharing: NO. Countries: 1. Publications: 1.
Faricimab Quarterly Maintenance for Neovascular Age Related Macular Degeneration
ClinicalTrials.gov study NCT06742307. IPD Sharing: YES. Countries: 1. Publications: 4.
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
ClinicalTrials.gov study NCT03823287. IPD Sharing: YES. Countries: 15. Publications: 4.
Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration
ClinicalTrials.gov study NCT02286089. IPD Sharing: YES. Countries: 2. Publications: 1.
A Study in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema to Evaluate the Safety of the Faricimab Prefilled Syringe
ClinicalTrials.gov study NCT05569148. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.